「引人入胜……拥有电影场景般的细节……」——《科学 Science》

▲Theranos公司创始人Elizabeth Holmes

她，被誉为“女版乔布斯”

用“一滴血”颠覆血液检测、翻转医疗产业

短短十年，成为硅谷首位身价数十亿美元的女性科技创业家

然而，一个爆料、一封匿名检举信，一位《华尔街日报》调查记者，

在六个月内，却使这高达90亿美元的生物科技独角兽极速崩解……

在本书中，作者John Carreyrou揭露了继“安然事件”之后规模极为庞大的企业诈欺案件，讲述了一个关于野心与被利益蒙蔽双眼的故事。

The full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers.

In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work.

A riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold prmises of Silicon Valley.

图 | Theranos的产品nanotainers

生物科技新创公司Theranos宣称，自家公司研发的机器只需要几滴血，就可以验出许多种疾病，此研究推翻了过往血液测量的方式。与传统的血液检测动辄数百美元的花费相比，Theranos只需要2.99美元。

社会各界对于这一“颠覆性”创新十分看好，各种头衔纷至沓来：女版“乔布斯”、美女创业者，2014年底，公司的估值达90亿美元，Theranos被评为仅次于特斯拉的“改变世界的创业公司”。

似乎，这一局Theranos稳赢了。但一切的美梦都随着《华尔街日报》的调查报告而变得粉碎，Holmes的传奇故事戛然而止……

John Carreyrou

《华尔街日报》调查记者，曾两度获得普利策奖（Pulitzer Prize）。 

他对Theranos的深入报导，获得了乔治·波克奖（George Polk Award）财经报导奖项、罗布杰出商业财经新闻奖（Gerald Loeb Award for Distinguished Business and Financial Journalism）的专题报导奖项，以及巴莱特&史提尔调查新闻银奖（Barlett & Steele Silver Award for Investigative Business Journalism）。